{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:23:48Z","timestamp":1789763028285,"version":"4.0.1"},"reference-count":50,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                  <jats:p>The effects of endocrinological treatment on cardiovascular risk profile in transgender adolescents are unknown. In this retrospective cohort study, we aim to investigate these effects and assess obesity and dyslipidemia prevalence in transgender adolescents at 22 years compared with peers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Changes in BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), glucose, homeostatic model assessment for insulin resistance (HOMA-IR), and lipid values during treatment, along with the prevalence of obesity and dyslipidemia at 22 years, were recorded in 71 transwomen and 121 transmen who started gonadotropin-releasing hormone agonists in their adolescence (15 years), with a subsequent addition of sex hormones (17 years).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>In transwomen, changes in BMI (+3.0; 95% confidence interval [CI] 1.6 to 4.4), SBP (\u22122 mm\u2009Hg; 95% CI \u22127 to 3), DBP (+10 mm\u2009Hg; 95% CI 7 to 14), glucose (0.0 mmol\/L; 95% CI \u22120.2 to 0.2), HOMA-IR (+0.6; 95% CI \u22120.6 to 1.9), and lipid values were similar or more favorable compared with peers. The same was true for transmen regarding changes in BMI (+2.3; 95% CI 1.7 to 2.9), SBP (+7 mm\u2009Hg; 95% CI 3 to 10), DBP (+7 mm\u2009Hg; 95% CI 5 to 10), glucose (+0.1 mmol\/L; 95% CI \u22120.1 to 0.3), HOMA-IR (\u22120.2; 95% CI \u22120.8 to 0.3), and lipid values. At age 22, obesity prevalence was 9.9% in transwomen, 6.6% in transmen, 2.2% in ciswomen, and 3.0% in cismen.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Generally, endocrinological treatment in transgender adolescents is safe regarding cardiovascular risk. Because obesity is more prevalent in transgender adolescents compared with peers, body weight management should be important during the medical trajectory.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2019-0741","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T13:25:34Z","timestamp":1582723534000},"source":"Crossref","is-referenced-by-count":62,"title":["Hormonal Treatment and Cardiovascular Risk Profile in Transgender Adolescents"],"prefix":"10.1542","volume":"145","author":[{"given":"Maartje","family":"Klaver","sequence":"first","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"de Mutsert","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Leiden, Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.T.C.","family":"van der Loos","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal M.","family":"Wiepjes","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W.R.","family":"Twisk","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Rotteveel","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Amsterdam, Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Klink","sequence":"additional","affiliation":[{"name":"Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"issue":"4","key":"2021121013091357500_B1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s007870050073","article-title":"Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent","volume":"7","author":"Cohen-Kettenis","year":"1998","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2021121013091357500_B2","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1530\/eje.1.02231","article-title":"Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects","volume":"155","author":"Delemarre-van de Waal","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"48","key":"2021121013091357500_B3","first-page":"834","article-title":"Gender identity disorders in childhood and adolescence: currently debated concepts and treatment strategies","volume":"105","author":"Korte","year":"2008","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"2021121013091357500_B4","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021121013091357500_B5","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/j.1743-6109.2010.01943.x","article-title":"Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study","volume":"8","author":"de Vries","year":"2011","journal-title":"J Sex Med"},{"issue":"2","key":"2021121013091357500_B6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jsxm.2017.12.009","article-title":"Early hormonal treatment affects body composition and body shape in young transgender adolescents","volume":"15","author":"Klaver","year":"2018","journal-title":"J Sex Med"},{"issue":"2","key":"2021121013091357500_B7","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1210\/jc.2014-2439","article-title":"Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria","volume":"100","author":"Klink","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021121013091357500_B8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-14-0011","article-title":"Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern","volume":"170","author":"Gooren","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2021121013091357500_B9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a Cohort Study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021121013091357500_B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2021121013091357500_B11","first-page":"2044","article-title":"Long-term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021121013091357500_B12","doi-asserted-by":"crossref","first-page":"e12660","DOI":"10.1111\/and.12660","article-title":"Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis","volume":"49","author":"Klaver","year":"2017","journal-title":"Andrologia"},{"issue":"5","key":"2021121013091357500_B13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology"},{"issue":"8","key":"2021121013091357500_B14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence [published correction appears in J Sex Med. 2016;13(4):732]","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"2021121013091357500_B15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/humrep\/deh053","article-title":"Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene","volume":"19","author":"Palomba","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"2021121013091357500_B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14485\/HBPR.1.2.8","article-title":"Weight-related disparities for transgender college students","volume":"1","author":"VanKim","year":"2014","journal-title":"Health Behav Policy Rev"},{"issue":"19","key":"2021121013091357500_B17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199211053271904","article-title":"Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935","volume":"327","author":"Must","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"2021121013091357500_B18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jadohealth.2011.06.006","article-title":"Body mass index at age 25 and all-cause mortality in whites and African Americans: the Atherosclerosis Risk in Communities study","volume":"50","author":"Stevens","year":"2012","journal-title":"J Adolesc Health"},{"issue":"5","key":"2021121013091357500_B19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.mcna.2011.06.003","article-title":"Obesity and dyslipidemia","volume":"95","author":"Franssen","year":"2011","journal-title":"Med Clin North Am"},{"issue":"5","key":"2021121013091357500_B20","doi-asserted-by":"crossref","first-page":"e20163173","DOI":"10.1542\/peds.2016-3173","article-title":"Cross-sex hormones and metabolic parameters in adolescents with gender dysphoria","volume":"139","author":"Jarin","year":"2017","journal-title":"Pediatrics"},{"key":"2021121013091357500_B21","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"4","key":"2021121013091357500_B22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jsxm.2018.01.016","article-title":"The Amsterdam Cohort of Gender Dysphoria study (1972-2015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","journal-title":"J Sex Med"},{"issue":"7","key":"2021121013091357500_B23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"6","key":"2021121013091357500_B24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"7","key":"2021121013091357500_B25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/oxfordjournals.aje.a009510","article-title":"Association of a central pattern of body fat with blood pressure and lipoproteins from adolescence into adulthood. The Amsterdam Growth and Health Study","volume":"147","author":"van Lenthe","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2021121013091357500_B26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/adc.82.2.107","article-title":"Body index measurements in 1996-7 compared with 1980","volume":"82","author":"Fredriks","year":"2000","journal-title":"Arch Dis Child"},{"issue":"10","key":"2021121013091357500_B27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1097\/00004872-200210000-00019","article-title":"Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions [published correction appears in J Hypertens. 2003;21(11):2205\u20132206]","volume":"20","author":"W\u00fchl","year":"2002","journal-title":"J Hypertens"},{"issue":"10, pt 1","key":"2021121013091357500_B28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0895-7061(95)00216-2","article-title":"24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender","volume":"8","author":"Wiinberg","year":"1995","journal-title":"Am J Hypertens"},{"issue":"7","key":"2021121013091357500_B29","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1210\/jc.2004-2001","article-title":"Ethnic differences in insulin resistance and body composition in United Kingdom adolescents","volume":"90","author":"Ehtisham","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021121013091357500_B30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.10.3.430","article-title":"Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study","volume":"10","author":"Manolio","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"2","key":"2021121013091357500_B31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00592-015-0782-4","article-title":"Reference ranges of HOMA-IR in normal-weight and obese young Caucasians","volume":"53","author":"Shashaj","year":"2016","journal-title":"Acta Diabetol"},{"issue":"1","key":"2021121013091357500_B32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.diabres.2011.07.015","article-title":"Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study","volume":"94","author":"Gayoso-Diz","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2021121013091357500_B33","doi-asserted-by":"crossref","first-page":"S6.e15","DOI":"10.1016\/j.jpeds.2009.04.051","article-title":"Growth curves for cardio-metabolic risk factors in children and adolescents","volume":"155","author":"Cook","year":"2009","journal-title":"J Pediatr"},{"issue":"11","key":"2021121013091357500_B34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.99.11.1471","article-title":"Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children\u2019s Blood Pressure Study","volume":"99","author":"Sinaiko","year":"1999","journal-title":"Circulation"},{"issue":"7244","key":"2021121013091357500_B35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"2021121013091357500_B36","volume-title":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents Full Report","author":"Daniels","year":"2012"},{"key":"2021121013091357500_B37","volume-title":"Physical Status: The Use and Interpretation of Anthropometry","author":"World Health Organization","year":"1995"},{"key":"2021121013091357500_B38","unstructured":"Centers for Disease Control and Prevention\n          . National Health and Nutrition Examination Survey: data files. Available at: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/nhanes3\/DataFiles.aspx. Accessed July 27, 2018"},{"issue":"1","key":"2021121013091357500_B39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/and.12389","article-title":"(Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male-female genetic differences","volume":"47","author":"Gooren","year":"2015","journal-title":"Andrologia"},{"issue":"8","key":"2021121013091357500_B40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1743-6109.2011.02311.x","article-title":"Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals","volume":"8","author":"Ott","year":"2011","journal-title":"J Sex Med"},{"issue":"2","key":"2021121013091357500_B41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1012690215583283","article-title":"\u2018People have a knack of making you feel excluded if they catch on to your difference\u2019: transgender experiences of exclusion in sport","volume":"52","author":"Hargie","year":"2017","journal-title":"Int Rev Sociol Sport"},{"issue":"4","key":"2021121013091357500_B42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.87.4.341","article-title":"Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults","volume":"87","author":"van der Sluis","year":"2002","journal-title":"Arch Dis Child"},{"issue":"2","key":"2021121013091357500_B43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12020-016-1019-1","article-title":"Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse","volume":"54","author":"Kelly","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"2021121013091357500_B44","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/0016-5085(92)91192-7","article-title":"Hepatic cholesterol metabolism in estrogen-treated men","volume":"103","author":"Angelin","year":"1992","journal-title":"Gastroenterology"},{"issue":"6, pt 1","key":"2021121013091357500_B45","first-page":"E851","article-title":"Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats","volume":"262","author":"Holm\u00e4ng","year":"1992","journal-title":"Am J Physiol"},{"issue":"2","key":"2021121013091357500_B46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(98)00022-7","article-title":"Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men [published correction appears in Atherosclerosis. 1998;138(2):403]","volume":"137","author":"Giri","year":"1998","journal-title":"Atherosclerosis"},{"issue":"2","key":"2021121013091357500_B47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02265258","article-title":"Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors","volume":"97","author":"Kauma","year":"1996","journal-title":"Hum Genet"},{"issue":"7","key":"2021121013091357500_B48","first-page":"2356","article-title":"Efficacy and safety of pubertal induction using 17\u03b2-estradiol in transgirls","volume":"102","author":"Hannema","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121013091357500_B49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0030-1255074","article-title":"Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist","volume":"119","author":"Mueller","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"2021121013091357500_B50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","article-title":"Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist","volume":"113","author":"Dittrich","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-0741\/1079284\/peds_20190741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-0741\/1079284\/peds_20190741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:52:12Z","timestamp":1639187532000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/145\/3\/e20190741\/36814\/Hormonal-Treatment-and-Cardiovascular-Risk-Profile"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,1]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-0741","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"article-number":"e20190741"}}